The control and treatment of disease due to staphylococci still present a serious medical problem in spite of the availability of many effective antibacterial agents. This is particularly true in the newborn nursery. With improved hygiene, better regulation of nurseries, and the use of potent antibiotics, staphylococcal infection still occurs with considerable frequency. Difficulties in the control of this infection lie both in the facility with which the organism is transmitted as well as in the variable antibiotic resistance patterns observed with hospital strains. Numerous studies and reviews of the epidemiology and bacteriology of nursery-acquired staphylococcal infections have appeared in the literature.1-12 A new derivative of penicillanic acid, 2,6-dimethoxyphenyl penicillin, appears to inhibit the growth, in vitro, of staphylococci resistant to penicillin G.13 Since this isomer is well absorbed on parenteral administration and has been shown to be nontoxic in animals, it appears to offer considerable promise in the prevention and treatment of staphylococcal infections. The present stud¬ ies have been designed to provide data re¬ garding the absorption, toxicity, and efficacy of this drug in the treatment of staphylo¬ coccal infections in infants and children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.